Article Details

AstraZeneca's Ondexxya approved in Japan to treat major bleeds - Morningstar

Retrieved on: 2022-03-29 08:14:15

Tags for this article:

Click the tags to see associated articles and topics

AstraZeneca's Ondexxya approved in Japan to treat major bleeds - Morningstar. View article details on hiswai:

Excerpt

(Alliance News) - AstraZeneca PLC on Tuesday said its reversal agent Ondexxya has been fully ...

Article found on: www.morningstar.co.uk

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up